PCIV Company OmnicPath AI Published in Nature BioTechnology
OmnicPath AI specializes in developing an end-to-end workflow that integrates Spatial Transcriptomics (ST) data and high-resolution histology images to predict spatial gene expression.
Robotics Growth in Philadelphia Highlighted
The Philadelphia Business Journal recently released an article about robotics growth in Philadelphia.
Penn Spinout EpiVario Announces Acquisition of Acetyl CoA Synthetase 2 (ACSS2) Inhibitor Portfolio from Metabomed LTD
Penn spinout EpiVario, a biotech company focusing on neuroepigenetics for addiction disorders, has acquired small molecule acetyl co-A synthetase-2 inhibitor (ACSS2i) portfolio.
Four Penn Startups Make The Philadelphia Business Journal’s PHL Inno List of 2024 Startups to Watch
Baleena, BlueWhale Bio, Treeswift and Verismo were all recognized.
Serpex Acquired by Maverix Medical
Serpex Medical leverages the power of steerable instruments to enable greater precision and access to improve the diagnosis and treatment of lung cancer.
Carisma Therapeutics Receives FDA Clearance of Investigational New Drug Application for CT-0525, a Novel CAR-M Cell Therapy
Having received a Study May Proceed notification from the FDA, Carisma plans to initiate a Phase 1 study in the months to come and to treat the first patient in the first half of 2024.
Penn’s Leadership Role in Philadelphia’s Rapidly Growing Life Sciences Industry Highlighted
Technical.ly published an article about the future of the growth of the life sciences in Philadelphia, highlighting Penn’s role in the development of the city as a strong tech hub.
Technical.ly State of the Philadelphia Tech Economy Report Highlights Innovation Accomplishments at Penn
According to the report, Penn ranked within the top five largest research & development expenditures of US universities in 2021.
ViTToria Biotherapeutics Secures $15M
ViTToria is focused on developing novel CAR-T cell therapies that transcend the limitations of current cell therapies.
Vivodyne Awarded Multiple Patents and Closed a $38 Million Seed Funding Round
Penn spinout Vivodyne closed a $38 million seed funding round led by Khosla Ventures.